This study is exploring a new, non-invasive way to check for lung rejection and infection in people who have received a lung transplant. Currently, doctors use procedures like bronchoscopies and lung biopsies, which can have risks and are costly. This study will use lung ultrasound, a painless procedure where a trained pulmonologist gently presses a probe to your chest, taking less than 10 minutes. The goal is to see if lung ultrasound can accurately predict rejection. You might be able to join if you are an adult (over 18) who has had a single, double, or heart-lung transplant, have no symptoms, normal breathing tests (spirometry), and a clear chest X-ray of your new lung. The study plans to enroll 90 participants, and its current status is unclear.

Study design

This is an interventional study planning to enroll 90 adult participants who have received a lung transplant.

What's involved

You would undergo a lung ultrasound, which is a non-invasive procedure taking less than 10 minutes.

Compensation

Not stated in the trial record.

Follow-up

The study will establish the predictive value of lung ultrasound from Month 0 to Month 12.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.